MENU
ANAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

AnaptysBio (ANAB) Ownership - Who owns AnaptysBio?

AnaptysBio Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
10770 Wateridge Circle
Phone
+1 858 362-6295
Employees
117
Web
https://www.anaptysbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.04B
P/E Ratio
N/A
Total Cash
265.71M
Projected Growth
N/A
Total Debt
15.1M
Revenue
123.16M
Risk (Beta)
0.61
Dividend Yield
N/A
Total Cash/Share
9.60
Total Debt/Equity
N/A
Revenue/Share
5.76 USD as % of share price

Fundamentals

ANAB
Capitalization
1.04B
P/E Ratio
N/A
Risk (Beta)
0.61
Dividend Yield
N/A
Total Cash
266M
Total Cash/Share
9.60
Total Debt
15.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.76%
Revenue
123M
ROE
N/A
Book Value
-44.73M
P/B Ratio
17.30
Cash Flow
N/A
Earnings
-4.39
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
28K
Current Ratio
8.22
Current Revenue Per Employee
163698.53
Dividends Per Share - Security
N/A
EBITDA
-59.63M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-34.77
Shares Held By Institutions
1.13B
Shares Outstanding - Current
27.7M
Total Liabilities
380M
Total Volume MTD
N/A
Value
-1
Gain YTD
184.592
View a ticker or compare two or three
ANAB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ANAB showed earnings on November 04, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a provider of therapeutic antibodies for inflammation and immuno-oncology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
10770 Wateridge Circle
Phone
+1 858 362-6295
Employees
117
Web
https://www.anaptysbio.com